Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update

被引：63

作者：

Aguado, Jose Maria ^{[1
]}

Ruiz-Camps, Isabel ^{[2
]}

Munoz, Patricia ^{[3
,4
]}

Mensa, Jose ^{[5
]}

Almirante, Benito ^{[2
]}

Vazquez, Lourdes ^{[6
]}

Rovira, Montserrat ^{[7
]}

Martin-Davila, Pilar ^{[8
]}

Moreno, Asuncion ^{[5
]}

Alvarez-Lerma, Francisco ^{[9
]}

Leon, Cristobal ^{[10
]}

Madero, Luis ^{[11
]}

Ruiz-Contreras, Jesus ^{[12
]}

Fortun, Jesus ^{[8
]}

Cuenca-Estrella, Manuel ^{[13
]}

机构：

[1] Hosp Univ 12 Octubre, Serv Enfernredades Infecciosas, Madrid, Spain

[2] Hosp Univ Vall Hebron, Serv Enfernredades Infecciosas, Barcelona, Spain

[3] Hosp Gen Univ Gregorio Maranon, Serv Microbiol Clin & Enfernredades Infecciosas, Madrid, Spain

[4] C1BER Enfermedades Resp CIBERES CD06 06 0, Palma de Mallorca, Spain

[5] Hosp Clin Barcelona, IDIBAPS, Serv Enfermedades Infecciosas, Barcelona, Spain

[6] Hosp Clin Univ, Serv Hematol, Salamanca, Spain

[7] Hosp Clin Barcelona, IDIBAPS, Serv Hematol, Barcelona, Spain

[8] Hosp Ramon & Cajal, Serv Enfermedades Infecciosas, E-28034 Madrid, Spain

[9] Hosp Univ Mar, Serv Med Intensiva, Barcelona, Spain

[10] Hosp Univ Valme, Serv Med Intensiva, Seville, Spain

[11] Hosp Nino Jesus, Serv Oncol & Hematol Pediat, Madrid, Spain

[12] Hosp Univ 12 Octubre, Serv Pediat, Madrid, Spain

[13] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Micol, Madrid, Spain

来源：

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2011年 / 29卷 / 05期

关键词：

Invasive fungal infection; Candida; Candidaemia; Invasive candidiasis; Cryptococcus; LIPOSOMAL AMPHOTERICIN-B; ORGAN TRANSPLANT RECIPIENTS; NEUTROPENIC CRITICALLY-ILL; INTENSIVE-CARE-UNIT; HEMATOPOIETIC STEM-CELL; BLOOD-STREAM INFECTION; ANTIFUNGAL MANAGEMENT-PRACTICES; CALCINEURIN-INHIBITOR AGENTS; PLACEBO-CONTROLLED TRIAL; CENTRAL VENOUS CATHETERS;

D O I：

10.1016/j.eimc.2011.01.008

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

These guidelines are an update of the recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) that were issued in 2004 (Enferm Infecc Microbial Clin. 2004,22:32-9) on the treatment of Invasive Candidiasis and infections produced by other yeasts. This 2010 update includes a comprehensive review of the new drugs that have appeared in recent years, as well as the levels of evidence for recommending them. These guidelines have been developed following the rules of the SEIMC by a working group composed of specialists in infectious diseases, clinical microbiology, critical care medicine, paediatrics and oncology-haematology. It provides a series of general recommendations regarding the management of invasive candidiasis and other yeast infections, as well as specific guidelines for prophylaxis and treatment, which have been divided into four sections: oncology-haematology, solid organ transplantation recipients, critical patients, and paediatric patients. (C) 2011 Elsevier Espana, S.L. All rights reserved.

引用

页码：345 / 361

页数：17

共 151 条

[1] COMBINED THERAPY WITH FLUCONAZOLE AND FLUCYTOSINE IN MURINE CRYPTOCOCCAL MENINGITIS
ALLENDOERFER, R
MARQUIS, AJ
RINALDI, MG
GRAYBILL, JR
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) : 726 - 729
[2] Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
Almirante, B
Rodríguez, D
Park, BJ
Cuenca-Estrella, M
Planes, AM
Almela, M
Mensa, J
Sanchez, F
Ayats, J
Gimenez, M
Saballs, P
Fridkin, SK
Morgan, J
Rodriguez-Tudela, JL
Warnock, DW
Pahissa, A
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) : 1829 - 1835
[3] Almirante Benito, 2007, Paediatr Drugs, V9, P311
[4] FLUCONAZOLE THERAPY FOR CHRONIC DISSEMINATED CANDIDIASIS IN PATIENTS WITH LEUKEMIA AND PRIOR AMPHOTERICIN-B THERAPY
ANAISSIE, E
BODEY, GP
KANTARJIAN, H
DAVID, C
BARNETT, K
BOW, E
DEFELICE, R
DOWNS, N
FILE, T
KARAM, G
POTTS, D
SHELTON, M
SUGAR, A
[J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02) : 142 - 150
[5] Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature
Anaissie, EJ
Darouiche, RO
AbiSaid, D
Uzun, O
Mera, J
Gentry, LO
Williams, T
Kontoyiannis, DP
Karl, CL
Bodey, GP
[J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) : 964 - 972
[6] Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B -: Clearance with voriconazole
Antachopoulos, C
Papakonstantinou, E
Dotis, J
Bibashi, E
Tamiolaki, M
Koliouskas, D
Roilides, E
[J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (05) : 283 - 285
[7] Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia
Asada, Noboru
Uryu, Hidetaka
Koseki, Mihoko
Takeuchi, Masami
Komatsu, Masaru
Matsue, Kosei
[J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (04) : E39 - E41
[8] Successful use of amphotericin B lipid complex in the treatment of cryptococcosis
Baddour, LM
Perfect, JR
Ostrosky-Zeichner, L
[J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 : S409 - S413
[9] PHARMACOKINETICS, OUTCOME OF TREATMENT, AND TOXIC EFFECTS OF AMPHOTERICIN-B AND 5-FLUOROCYTOSINE IN NEONATES
BALEY, JE
MEYERS, C
KLIEGMAN, RM
JACOBS, MR
BLUMER, JL
[J]. JOURNAL OF PEDIATRICS, 1990, 116 (05) : 791 - 797
[10] Voriconazole for Cryptococcal Meningitis in Children with Leukemia or Receiving Allogeneic Hemopoietic Stem Cell Transplant
Bandettini, R.
Castagnola, E.
Calvillo, M.
Micalizzi, C.
Ravegnani, M.
Pescetto, L.
Manzitti, C.
Soro, O.
Ricagni, L.
Lanino, E.
Miano, M.
Cuzzubbo, D.
Conte, M.
Morreale, G.
Faraci, M.
[J]. JOURNAL OF CHEMOTHERAPY, 2009, 21 (01) : 108 - 109

← 1 2 3 4 5 6 7 8 9 10 →